Skip to main content
main-content

01.05.2014 | Endocrine Tumors | Ausgabe 5/2014

Annals of Surgical Oncology 5/2014

Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience

Zeitschrift:
Annals of Surgical Oncology > Ausgabe 5/2014
Autoren:
MD A. Mohebati, BA M. DiLorenzo, BA F. Palmer, MD S. G. Patel, MD D. Pfister, MD N. Lee, MD R. M. Tuttle, MD A. R. Shaha, MD J. P. Shah, MD, PhD I. Ganly
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1245/​s10434-014-3545-5) contains supplementary material, which is available to authorized users.

Abstract

Background

Anaplastic thyroid carcinoma (ATC) is among the most aggressive solid tumors accounting for 1–5 % of primary thyroid malignancies. In this retrospective review, we aim to evaluate the prognostic factors, treatment approaches, and outcomes of patients with ATC treated at a single institution.

Materials and Methods

We retrospectively identified 95 patients with ATC from an institutional database between 1985 and 2010. A total of 83 patients with sufficient records were included in this study. Patient, tumor, and treatment characteristics were recorded. Disease-specific survival (DSS) was determined by the Kaplan–Meier method, and factors predictive of outcome were determined by univariate and multivariate analysis.

Results

Of the 83 patients, 41 were male and 42 were female. The median age at presentation was 60 years (range 28–89 years) with a median survival of 8 months. The 1- and 2-year DSS were 33 and 23 %, respectively. On univariate analysis, age less than 60 years, clinically N0 neck, absence of clinical extrathyroidal extension (cETE), gross total resection, and multimodality treatment were statistically significant predictors of improved survival. On multivariate analysis, absence of cETE, multimodality therapy, and gross total resection were predictors of improved outcome.

Conclusions

In patients with locoregional limited disease, multimodality treatment with gross total surgical resection and postoperative radiotherapy with or without chemotherapy offers the best local control and DSS.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
Supplementary material 1 (DOCX 17 kb)
10434_2014_3545_MOESM1_ESM.docx
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 5/2014

Annals of Surgical Oncology 5/2014Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise